Edition:
United Kingdom

Bavarian Nordic A/S (BAVA.CO)

BAVA.CO on Copenhagen Stock Exchange

179.35DKK
9:01am BST
Change (% chg)

kr.0.35 (+0.20%)
Prev Close
kr.179.00
Open
kr.179.15
Day's High
kr.179.75
Day's Low
kr.177.95
Volume
9,103
Avg. Vol
148,531
52-wk High
kr.202.80
52-wk Low
kr.117.75

About

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)

Overall

Beta: 1.55
Market Cap(Mil.): kr.5,785.38
Shares Outstanding(Mil.): 32.32
Dividend: --
Yield (%): --

Financials

  BAVA.CO Industry Sector
P/E (TTM): -- 30.33 34.23
EPS (TTM): -8.68 -- --
ROI: -10.59 12.99 12.65
ROE: -12.63 14.18 17.19

BRIEF-Bavarian Nordic REPORTS Positive Result From Phase 2 Trial Evaluating BN-Brachyury In Chordoma

* REPORTED ON WEDNESDAY POSITIVE RESULT FROM ONGOING PHASE 2 TRIAL EVALUATING BN-BRACHYURY IN CHORDOMA

06 Jun 2019

Earnings vs. Estimates